Director/PDMR Shareholding

RNS Number : 8434D

Allergy Therapeutics PLC

29 March 2011

 



29 March 2011

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

Director/PDMR Shareholding

Allergy Therapeutics plc (AIM: AGY), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, was informed on 29^th March 2011 that Mr Ignace Goethals, a non-executive director, purchased 115,197 Ordinary Shares of 0.1p each ('Ordinary Shares') on 29^th March 2011 at a price of 8.6p per Ordinary Share.

Following this share purchase Mr Ignace Goethals holds 5,013,109 Ordinary Shares representing 1.61 per cent. of the issued share capital of the Company.

For further information

Allergy Therapeutics	[phone]
Manuel Llobet, Chief Executive Officer
Ian Postlethwaite, Finance Director
www.allergytherapeutics.com
Nomura Code Securities	[phone]
Juliet Thompson/ Clare Terlouw
Financial Dynamics	[phone]
Ben Brewerton/ Susan Quigley

 

END

 

 

RDSBSGDXRBDBGBC